HNRNPD and hepatocellular carcinoma: Taken together, these results demonstrated that lower circLARP1B levels were unfavorable to HCC progression, lipid accumulation, and metastasis in mouse models, by affecting the same circLARP1B–HNRNPD–LKB1–AMPK regulatory pathway identified in HCC cell lines.